Aytu BioScience is trading 5.03% down now at $1.89 after closing at $1.99 on September 15, 2026, amid a broader biotech-sector selloff.
- No verified company-specific announcement, earnings release, FDA action, or regulatory filing has been identified for September 16, 2026.
- XBI is down 2.11% as investors react to disappointing pelacarsen trial results and wider commercial-biotech weakness.